Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/033,639external-prioritypatent/US4381295A/en
Application filed by Ortho Pharma CorpfiledCriticalOrtho Pharma Corp
Publication of FI844705LpublicationCriticalpatent/FI844705L/en
Publication of FI844705A0publicationCriticalpatent/FI844705A0/en
Publication of FI75230BpublicationCriticalpatent/FI75230B/en
Application grantedgrantedCritical
Publication of FI75230CpublicationCriticalpatent/FI75230C/en
FI844705A1979-04-261984-11-29
DIAGNOSTIC FOERFARANDE, VID VILKET ANVAENDS EN NY MONOCLONAL ANTIKROPP SPECIFIK MOT MAENNISKANS HJAELPARE-T-CELLER OCH I FOERFARANDET ANVAENDBAR COMPOSITION.
FI75230C
(en)
DIAGNOSTIC FOERFARANDE, VID VILKET ANVAENDS EN NY MONOCLONAL ANTIKROPP SPECIFIK MOT MAENNISKANS HJAELPARE-T-CELLER OCH I FOERFARANDET ANVAENDBAR COMPOSITION.
DIAGNOSTIC FOERFARANDE FOER PAOVISANDE AV UNDERSKOTT ELLER OEVERSKOTT PAO EN SPECIFIC T-CELLPOPULATION UNDER ANVAENDNING AV EN MONOCLONAL ANTIKROPP SPECIFIK MOT MAENNISKANS TYMOCYTANTIGEN.